ctDNA status may also inform treatment plan. Breast cancer is the most common form of non-skin cancer in the United States, and human epidermal growth factor receptor 2-positive breast cancer, or HER2-positive breast cancer,...
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
Recently updated federal guidelines for cervical cancer screening and the HPV vaccine could make these prevention strategies more convenient.
Guidelines now recommend self-administered HPV tests for cervical cancer screening, and adding megestrol to hormone therapy slows tumor growth.
Adding immunotherapy to treatment improves outcomes for people with a high-risk form of this common skin cancer.
The countdown to the new year is nearly upon us, but no need to count down to the last installment of Editors’ Picks in 2025 … because here it is! With articles on everything...
Immune checkpoint inhibitor improves survival in people with limited-stage small cell lung cancer.
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast cancer care.
Proton therapy for oropharyngeal cancer increases overall survival, and risk-based screening for breast cancer appears to be as effective as annual screening.
A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged in 2025.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More